1 July 2024 false Taxfiler 2024.6 true 9616590 business:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 9616590 2024-06-30 9616590 2024-07-01 2025-06-30 9616590 business:AuditExemptWithAccountantsReport 2024-07-01 2025-06-30 9616590 business:FilletedAccounts 2024-07-01 2025-06-30 9616590 2025-06-30 9616590 business:Director1 2024-07-01 2025-06-30 9616590 business:RegisteredOffice 2024-07-01 2025-06-30 9616590 2024-06-30 9616590 core:WithinOneYear 2025-06-30 9616590 core:WithinOneYear 2024-06-30 9616590 core:AfterOneYear 2025-06-30 9616590 core:AfterOneYear 2024-06-30 9616590 core:ShareCapital core:PreviouslyStatedAmount 2025-06-30 9616590 core:ShareCapital core:PreviouslyStatedAmount 2024-06-30 9616590 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-06-30 9616590 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-06-30 9616590 core:PreviouslyStatedAmount 2025-06-30 9616590 core:PreviouslyStatedAmount 2024-06-30 9616590 business:SmallEntities 2024-07-01 2025-06-30 9616590 countries:EnglandWales 2024-07-01 2025-06-30 9616590 core:LandBuildings 2024-07-01 2025-06-30 9616590 core:PlantMachinery 2024-07-01 2025-06-30 9616590 core:FurnitureFittings 2024-07-01 2025-06-30 9616590 core:ComputerEquipment 2024-07-01 2025-06-30 9616590 core:LandBuildings 2024-06-30 9616590 core:PlantMachinery 2024-06-30 9616590 core:FurnitureFittings 2024-06-30 9616590 core:ComputerEquipment 2024-06-30 9616590 core:LandBuildings 2025-06-30 9616590 core:PlantMachinery 2025-06-30 9616590 core:FurnitureFittings 2025-06-30 9616590 core:ComputerEquipment 2025-06-30 9616590 business:OrdinaryShareClass1 2024-07-01 2025-06-30 9616590 business:OrdinaryShareClass1 2023-07-01 2024-06-30 9616590 2023-07-01 2024-06-30 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 9616590 (England and Wales)
PROLASE CLINICS LTD Unaudited accounts for the year ended 30 June 2025
PROLASE CLINICS LTD Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
PROLASE CLINICS LTD Company Information for the year ended 30 June 2025
Director
MS K M MOORHOUSE
Company Number
9616590 (England and Wales)
Registered Office
27 Bridge Street Hitchin Hertfordshire SG5 2DF England
Accountants
NUMBER CRUNCHING LTD UNIT 5 FEN END STOTFOLD HERTS SG5 4BA
- 3 -
PROLASE CLINICS LTD Statement of financial position as at 30 June 2025
2025
2024
Notes
£
£
Fixed assets
Tangible assets
4
1,724
3,688
Current assets
Debtors
5
30,812
10,003
Cash at bank and in hand
13,730
22,304
44,542
32,307
Creditors: amounts falling due within one year
6
(115,650)
(120,708)
Net current liabilities
(71,108)
(88,401)
Total assets less current liabilities
(69,384)
(84,713)
Creditors: amounts falling due after more than one year
7
-
(8,750)
Provisions for liabilities
Deferred tax
(586)
(959)
Net liabilities
(69,970)
(94,422)
Capital and reserves
Called up share capital
8
100
100
Profit and loss account
(70,070)
(94,522)
Shareholders' funds
(69,970)
(94,422)
For the year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 10 March 2026 and were signed on its behalf by
MS K M MOORHOUSE Director Company Registration No. 9616590
- 4 -
PROLASE CLINICS LTD Notes to the Accounts for the year ended 30 June 2025
1
Statutory information
PROLASE CLINICS LTD is a private company, limited by shares, registered in England and Wales, registration number 9616590. The registered office is 27 Bridge Street, Hitchin, Hertfordshire, SG5 2DF, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Land & buildings
10% straight line
Plant & machinery
25% straight line
Fixtures & fittings
25% straight line
Computer equipment
over 3 years
Going concern
The director and shareholders have confirmed that they will continue to give financial support to the company until such time as its position improves. In addition, the director and shareholders have confirmed that they will not recall their loans within 12 months. The director considers that it is appropriate to prepare the financial statements on a going concern basis. The financial statements do not include any adjustments that would result if the financial support were withdrawn.
Deferred taxation
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
- 5 -
PROLASE CLINICS LTD Notes to the Accounts for the year ended 30 June 2025
4
Tangible fixed assets
Land & buildings
Plant & machinery
Fixtures & fittings
Computer equipment
Total
£
£
£
£
£
Cost or valuation
At cost
At cost
At cost
At cost
At 1 July 2024
6,295
77,743
3,956
3,182
91,176
At 30 June 2025
6,295
77,743
3,956
3,182
91,176
Depreciation
At 1 July 2024
5,393
75,422
3,491
3,182
87,488
Charge for the year
629
1,185
150
-
1,964
At 30 June 2025
6,022
76,607
3,641
3,182
89,452
Net book value
At 30 June 2025
273
1,136
315
-
1,724
At 30 June 2024
902
2,321
465
-
3,688
5
Debtors
2025
2024
£
£
Amounts falling due within one year
Trade debtors
-
191
Other debtors
30,812
9,812
30,812
10,003
6
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans and overdrafts
-
5,000
VAT
6,291
4,093
Trade creditors
-
507
Taxes and social security
1,008
630
Other creditors
33,191
34,844
Loans from directors
74,560
75,034
Accruals
600
600
115,650
120,708
7
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans
-
8,750
8
Share capital
2025
2024
£
£
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100
100
9
Average number of employees
During the year the average number of employees was 6 (2024: 5).
- 6 -